10-K Decoder · All companies

Ligand Pharmaceuticals Incorporated

LGND · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$268M$167M+60.4%
Operating income$41.0M−$22.6M
Net income$124M−$4.03M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 30, 2026

$Q3 2026Year earlierChange
Revenue$78.7M$116M−31.9%
Operating income−$15.8M$55.4M
Net income−$28.5M$117M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Ligand's revenue in FY2025?
$268M in FY2025 (Fiscal year ended Dec 31, 2025), +60.4% vs $167M a year earlier, per its 10-K filed Feb 2026.
Was Ligand profitable in FY2025?
Yes: net income was $124M and operating income $41.0M in FY2025.
What was Ligand's revenue in Q3 2026?
$78.7M (−31.9% vs a year earlier), per its Form 10-Q filed Oct 30, 2026.